Macrophage‐Driven Bidirectional Exacerbation in Psoriasis‐Atherosclerosis Comorbidity: Insights From a Novel Mouse Model
Mediators of Inflammation · 2026-01 · 2026 (1)
DOI: 10.1155/mi/1377824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 26.07.2026. Verfasst von Fangshun Tan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chine…. Hauptthemen laut MEDLINE: Psoriasis, Atherosclerosis, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, Postdoctoral Fellowship Program of China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Background
Psoriasis (PSO) and atherosclerosis (AS) are chronic inflammatory diseases that frequently coexist, with each condition exacerbating the other. However, the underlying mechanisms remain poorly understood, partly due to the lack of a suitable animal model that recapitulates this bidirectional comorbidity.
Methods
PSO‐AS mouse models were constructed by combining high‐fat diet (HFD)–induced AS with imiquimod (IMQ)‐triggered psoriatic inflammation in ApoE −/− mice. PSO severity was assessed via skin manifestation, hematoxylin and eosin (H&E) staining, PSO area and severity index (PASI) score, quantitative real‐time PCR (qRT‐PCR), and serum ELISA, while AS was assessed by en face Oil red O (ORO) staining of aorta, H&E staining, ORO staining, Sirius Red (SR) staining, and immunofluorescence (IF) staining of the aortic root section. Mechanistic insights were obtained via proteomics, machine learning (ML), and validation of macrophage polarization in both skin and plaques.
Results
Chronic PSO model more closely resembles real‐world conditions than acute PSO model. Combining the IMQ application with a HFD, both the PSO‐AS group and the PSO group developed obvious psoriatic skin lesion, but the PSO‐AS group showed the highest epidermal thickness, PASI scores, and expression levels of psoriatic biomarkers (Interleukin‐17A [IL‐17A] and Interleukin‐23 [IL‐23]) and inflammatory factors (e.g., tumor necrosis factor alpha [TNF‐α] and Interleukin‐6 [IL‐6]), implying that AS may exacerbate PSO. Similarly, the PSO‐AS and AS groups both developed obvious plaque in the aorta, while the PSO‐AS group has the largest plaque area, necrotic core (NC) area, lipid content with the least fibrous cap (FC) thickness, and collagen content, illustrating that PSO conspicuously aggravated AS progression and led to an unstable plaque shift. Statistical analysis also confirms that PSO and AS mutually exacerbate each other, forming a vicious cycle that may be strongly associated with IL‐17. Proteomics and ML revealed marked M1 macrophage polarization in PSO‐AS mice. Validation by Western blot and IF showed upregulated M1 markers (CD86) and downregulated M2 markers (CD163) in both skin lesions and aortic roots, indicating that M1‐skewed macrophages fuel the vicious cycle. Besides, we explore that IFIT3 may serve as a promising biomarker for M1 macrophages in PSO‐AS skin.
Conclusions
This novel PSO‐AS mouse model faithfully recapitulates the bidirectional exacerbation seen clinically and uncovers M1 macrophage polarization as a key driver of this comorbidity. The model provides a robust platform for mechanistic and therapeutic studies of PSO‐associated cardiovascular disease (CVD).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beiji…
- Cardiac Arrhythmia Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medi…
- Department of Dermatology, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, hust.edu.cn.
- Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan, China, rmhospital.com.
- Beijing Key Laboratory of Xenotransplantation, Animal Experimental Centre, Fuwai Hospital, National Centre for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037…
- Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China, hust.edu.cn.
ORCID-Profile: Fangshun Tan, Yu Jiang, Ruizhi Wang, Ziquan Hu, Yuting Xia, Qi Pan, Liang Zhao, Jing Xu, Jiajia Lan, Menglu Liu, Jiafei Li, Mengyuan Wang, Wenjie Yan, Tianlang Zhao, Juan Tao, Weixian Yang
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation
- Postdoctoral Fellowship Program of China Postdoctoral Science Foundation
Zitieren
APA
Tan, F., Jiang, Y., Wang, R., Hu, Z., Xia, Y., Pan, Q., Zhao, L., Xu, J., Lan, J., Liu, M., Li, J., Wang, M., Yan, W., Zhao, T., Tao, J., & Yang, W. (2026). Macrophage‐Driven Bidirectional Exacerbation in Psoriasis‐Atherosclerosis Comorbidity: Insights From a Novel Mouse Model. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/1377824
Vancouver
Tan F, Jiang Y, Wang R, Hu Z, Xia Y, Pan Q, et al. Macrophage‐Driven Bidirectional Exacerbation in Psoriasis‐Atherosclerosis Comorbidity: Insights From a Novel Mouse Model. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/1377824
BibTeX
@article{Tan2026,
author = {Tan, Fangshun and Jiang, Yu and Wang, Ruizhi and Hu, Ziquan and Xia, Yuting and Pan, Qi and Zhao, Liang and Xu, Jing and Lan, Jiajia and Liu, Menglu and Li, Jiafei and Wang, Mengyuan and Yan, Wenjie and Zhao, Tianlang and Tao, Juan and Yang, Weixian},
title = {Macrophage‐Driven Bidirectional Exacerbation in Psoriasis‐Atherosclerosis Comorbidity: Insights From a Novel Mouse Model},
journal = {Mediators of Inflammation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/mi/1377824}
}
EUVIMED